Celestica Financials
This page shows Celestica (CLS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Celestica is turning added sales into profit much faster, helped by a leaner overhead base and stronger margin drop-through.
From FY2023 to FY2025, gross profit increased by$740M while SG&A fell by$43M , so a much larger share of each new sales dollar reached operating income instead of being absorbed by overhead. That margin step-up also became more working-capital intensive: FY2025 operating cash flow was about79.2% of net income after inventory climbed by$427M .
The balance sheet strengthened alongside profitability: long-term debt ended FY2025 at
This growth still looks cash generative after reinvestment, not just profitable on paper, because higher investment has not erased the cash created by operations. Capital spending rose to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Celestica's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Celestica has an operating margin of 8.4%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 62/100, indicating healthy but not exceptional operating efficiency. This is up from 6.2% the prior year.
Celestica's revenue surged 28.5% year-over-year to $12.4B, reflecting rapid business expansion. This strong growth earns a score of 86/100.
Celestica carries a low D/E ratio of 0.34, meaning only $0.34 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.
Celestica's current ratio of 1.44 indicates adequate short-term liquidity, earning a score of 39/100. The company can meet its near-term obligations, though with limited headroom.
Celestica has a free cash flow margin of 3.7%, earning a moderate score of 41/100. The company generates positive cash flow after capital investments, but with room for improvement.
Celestica earns a strong 37.6% return on equity (ROE), meaning it generates $38 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is up from 22.6% the prior year.
Celestica scores 7.33, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($39.7B) relative to total liabilities ($5.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Celestica passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Celestica generates $0.79 in operating cash flow ($659.5M OCF vs $832.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Celestica earns $19.8 in operating income for every $1 of interest expense ($1.0B vs $52.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Celestica generated $12.4B in revenue in fiscal year 2025. This represents an increase of 28.5% from the prior year.
Celestica's EBITDA was $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 61.9% from the prior year.
Celestica reported $832.5M in net income in fiscal year 2025. This represents an increase of 94.5% from the prior year.
Celestica earned $7.16 per diluted share (EPS) in fiscal year 2025. This represents an increase of 98.3% from the prior year.
Cash & Balance Sheet
Celestica generated $458.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 51.3% from the prior year.
Celestica held $595.6M in cash against $750.5M in long-term debt as of fiscal year 2025.
Celestica had 115M shares outstanding in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Margins & Returns
Celestica's gross margin was 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the prior year.
Celestica's operating margin was 8.4% in fiscal year 2025, reflecting core business profitability. This is up 2.2 percentage points from the prior year.
Celestica's net profit margin was 6.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.3 percentage points from the prior year.
Celestica's ROE was 37.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 15.0 percentage points from the prior year.
Capital Allocation
Celestica invested $118.2M in research and development in fiscal year 2025. This represents an increase of 51.5% from the prior year.
Celestica spent $153.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 0.9% from the prior year.
Celestica invested $201.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 17.7% from the prior year.
CLS Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B+10.7% | $3.7B+14.4% | $3.2B+10.4% | $2.9B+9.2% | $2.6B+4.0% | $2.5B+1.8% | $2.5B+4.5% | $2.4B |
| Cost of Revenue | $3.6B+12.0% | $3.2B+16.0% | $2.8B+10.1% | $2.5B+6.2% | $2.4B+5.6% | $2.2B+0.4% | $2.2B+4.7% | $2.1B |
| Gross Profit | $437.2M+0.9% | $433.1M+4.1% | $416.1M+12.2% | $371.0M+35.5% | $273.9M-7.8% | $297.2M+14.0% | $260.6M+2.7% | $253.8M |
| R&D Expenses | $41.2M+36.4% | $30.2M-17.0% | $36.4M+7.1% | $34.0M+93.2% | $17.6M-24.8% | $23.4M+25.1% | $18.7M-3.6% | $19.4M |
| SG&A Expenses | $117.4M+67.5% | $70.1M+82.6% | $38.4M-1.3% | $38.9M-65.4% | $112.5M+95.3% | $57.6M-37.3% | $91.8M+15.8% | $79.3M |
| Operating Income | $272.1M-13.5% | $314.4M-3.3% | $325.0M+19.3% | $272.5M+111.6% | $128.8M-36.4% | $202.6M+46.8% | $138.0M+3.8% | $132.9M |
| Interest Expense | $16.0M+27.0% | $12.6M-1.6% | $12.8M-5.2% | $13.5M-1.5% | $13.7M+15.1% | $11.9M+6.3% | $11.2M-25.3% | $15.0M |
| Income Tax | $44.0M+30.2% | $33.8M-21.6% | $43.1M-6.9% | $46.3M+68.4% | $27.5M-27.2% | $37.8M+9.6% | $34.5M+86.5% | $18.5M |
| Net Income | $212.3M-20.6% | $267.5M-0.1% | $267.8M+26.9% | $211.0M+144.8% | $86.2M-43.2% | $151.7M+69.5% | $89.5M-5.8% | $95.0M |
| EPS (Diluted) | $1.83 | N/A | $2.31+26.9% | $1.82+145.9% | $0.74 | N/A | $0.75-6.3% | $0.80 |
CLS Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.3B+14.5% | $7.2B+9.2% | $6.6B+5.9% | $6.2B+7.0% | $5.8B-2.6% | $6.0B | N/A | N/A |
| Current Assets | $6.4B+12.8% | $5.7B+10.3% | $5.1B+7.8% | $4.8B+9.0% | $4.4B-3.0% | $4.5B | N/A | N/A |
| Cash & Equivalents | $378.0M-36.5% | $595.6M+94.7% | $305.9M-2.5% | $313.8M+3.6% | $303.0M-28.4% | $423.3M+6.2% | $398.5M-8.2% | $434.0M |
| Inventory | $2.7B+22.2% | $2.2B+6.9% | $2.0B+6.7% | $1.9B+7.3% | $1.8B+1.6% | $1.8B | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $333.0M0.0% | $333.1M-2.2% | $340.7M0.0% | $340.8M+0.1% | $340.5M0.0% | $340.5M | N/A | N/A |
| Total Liabilities | $6.2B+23.3% | $5.0B+9.1% | $4.6B+2.1% | $4.5B+4.8% | $4.3B+4.5% | $4.1B | N/A | N/A |
| Current Liabilities | $5.1B+29.0% | $3.9B+12.5% | $3.5B+5.5% | $3.3B+8.7% | $3.1B+1.1% | $3.0B | N/A | N/A |
| Long-Term Debt | $746.5M-0.5% | $750.5M-0.8% | $756.7M-10.8% | $848.6M-7.3% | $915.0M+18.8% | $770.2M | N/A | N/A |
| Total Equity | $2.1B-5.3% | $2.2B+9.3% | $2.0B+15.4% | $1.8B+12.9% | $1.6B-17.9% | $1.9B+4.5% | $1.8B+0.9% | $1.8B |
| Retained Earnings | N/A | $408.7M | N/A | N/A | N/A | -$423.8M | N/A | N/A |
CLS Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $356.3M+42.2% | $250.6M+98.6% | $126.2M-17.2% | $152.4M+17.0% | $130.3M-9.1% | $143.4M+16.8% | $122.8M+23.3% | $99.6M |
| Capital Expenditures | $229.5M+142.3% | $94.7M+153.9% | $37.3M+14.8% | $32.5M-11.4% | $36.7M-22.9% | $47.6M+3.5% | $46.0M+24.7% | $36.9M |
| Free Cash Flow | $126.8M-18.7% | $155.9M+75.4% | $88.9M-25.9% | $119.9M+28.1% | $93.6M-2.3% | $95.8M+24.7% | $76.8M+22.5% | $62.7M |
| Investing Cash Flow | -$218.4M-130.6% | -$94.7M-153.9% | -$37.3M-6.6% | -$35.0M+4.6% | -$36.7M+28.0% | -$51.0M0.0% | -$51.0M+27.2% | -$70.1M |
| Financing Cash Flow | -$355.5M-365.7% | $133.8M+238.2% | -$96.8M+9.2% | -$106.6M+50.2% | -$213.9M-216.4% | -$67.6M+37.0% | -$107.3M-211.3% | $96.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $22.6M-36.7% | $35.7M | $0-100.0% | $40.0M-48.5% | $77.7M+204.7% | $25.5M-74.5% | $100.0M+900.0% | $10.0M |
CLS Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8%-1.0pp | 11.8%-1.2pp | 13.0%+0.2pp | 12.8%+2.5pp | 10.3%-1.3pp | 11.7%+1.2pp | 10.4%-0.2pp | 10.6% |
| Operating Margin | 6.7%-1.9pp | 8.6%-1.6pp | 10.2%+0.8pp | 9.4%+4.6pp | 4.9%-3.1pp | 8.0%+2.4pp | 5.5%-0.0pp | 5.6% |
| Net Margin | 5.3%-2.1pp | 7.3%-1.1pp | 8.4%+1.1pp | 7.3%+4.0pp | 3.3%-2.7pp | 6.0%+2.4pp | 3.6%-0.4pp | 4.0% |
| Return on Equity | 10.1%-2.0pp | 12.1%-1.1pp | 13.2%+1.2pp | 12.0%+6.5pp | 5.5%-2.5pp | 8.0%+3.1pp | 4.9%-0.4pp | 5.3% |
| Return on Assets | 2.6%-1.1pp | 3.7%-0.3pp | 4.0%+0.7pp | 3.4%+1.9pp | 1.5%-1.0pp | 2.5% | N/A | N/A |
| Current Ratio | 1.26-0.2 | 1.44-0.0 | 1.47+0.0 | 1.440.0 | 1.43-0.1 | 1.49 | N/A | N/A |
| Debt-to-Equity | 0.36+0.0 | 0.34-0.0 | 0.37-0.1 | 0.48-0.1 | 0.59+0.2 | 0.41 | N/A | N/A |
| FCF Margin | 3.1%-1.1pp | 4.3%+1.5pp | 2.8%-1.4pp | 4.1%+0.6pp | 3.5%-0.2pp | 3.8%+0.7pp | 3.1%+0.5pp | 2.6% |
Similar Companies
Frequently Asked Questions
What is Celestica's annual revenue?
Celestica (CLS) reported $12.4B in total revenue for fiscal year 2025. This represents a 28.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Celestica's revenue growing?
Celestica (CLS) revenue grew by 28.5% year-over-year, from $9.6B to $12.4B in fiscal year 2025.
Is Celestica profitable?
Yes, Celestica (CLS) reported a net income of $832.5M in fiscal year 2025, with a net profit margin of 6.7%.
What is Celestica's EBITDA?
Celestica (CLS) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Celestica have?
As of fiscal year 2025, Celestica (CLS) had $595.6M in cash and equivalents against $750.5M in long-term debt.
What is Celestica's gross margin?
Celestica (CLS) had a gross margin of 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Celestica's operating margin?
Celestica (CLS) had an operating margin of 8.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Celestica's net profit margin?
Celestica (CLS) had a net profit margin of 6.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Celestica's return on equity (ROE)?
Celestica (CLS) has a return on equity of 37.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Celestica's free cash flow?
Celestica (CLS) generated $458.3M in free cash flow during fiscal year 2025. This represents a 51.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Celestica's operating cash flow?
Celestica (CLS) generated $659.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Celestica's total assets?
Celestica (CLS) had $7.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Celestica's capital expenditures?
Celestica (CLS) invested $201.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Celestica spend on research and development?
Celestica (CLS) invested $118.2M in research and development during fiscal year 2025.
What is Celestica's current ratio?
Celestica (CLS) had a current ratio of 1.44 as of fiscal year 2025, which is considered adequate.
What is Celestica's debt-to-equity ratio?
Celestica (CLS) had a debt-to-equity ratio of 0.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Celestica's return on assets (ROA)?
Celestica (CLS) had a return on assets of 11.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Celestica's Altman Z-Score?
Celestica (CLS) has an Altman Z-Score of 7.33, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Celestica's Piotroski F-Score?
Celestica (CLS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Celestica's earnings high quality?
Celestica (CLS) has an earnings quality ratio of 0.79x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Celestica cover its interest payments?
Celestica (CLS) has an interest coverage ratio of 19.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Celestica?
Celestica (CLS) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.